3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Breast Neoplasms
3
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Cervical Cancer
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Motor Activity
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Lymphoid
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gynecologic Cancer
1
Genetic Testing
1
Interventions
Magnetic Resonance Spectroscopy
6
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Temozolomide
2
Cyclophosphamide
2
Cisplatin
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Triiodothyronine
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Platinum
1
Pharmacogenomic Variants
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Surveys and Questionnaires
×
30 days
×
Clear all
No trials found.